曲美他嗪对冠心病稳定性劳力型心绞痛患者心肌缺血的影响

Abstract
Figure/Table
References (16)
Related Citation (6)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of Trimetazidine on myocardial ischemia in patients with coronary heart disease(CHD)complicated with stable exertional angina pectoris.Methods 90 patients with CHD complicated with stable exertional angina pectoris treated by our hospital from May 2014 to April 2016 were selected as research objects.They were evenly divided into two groups by computer randomization with 45 cases in each group.In control group,conventional drug therapy was used,while in research group,on the basis of the conventional drug therapy,Trimetazidine was added. The motion testing outcome,frequency of angina pectoris attack in one week,heart rate,heart rate-systolic blood pressure product,and therapeutic effect were compared between two groups.Results The motion testing outcome of the observa tion group∶ST segment lasting 1 mm[(405.39±52.16)s],attack time of exercise-induced angina pectoris[(453.26±59.24)s], the exercise-lasting time[(681.26±53.46)s]was longer than those of control group[(314.26±52.16)s,(351.34±50.31)s, (505.34±41.36)s](P＜0.05).The frequency of angina pectoris attack in one week[(1.34±0.28)times]in the observation group was obviously fewer than that of control group[(4.56±1.25)times](P＜0.05).There was no statistical difference in heart rate and heart rate-systolic blood pressure product between two groups(P＞0.05).The total effective rate(95.56%) in observation group was higher than that of the control group(68.89%)(P＜0.05).Conclusion Trimetazidine is an effective drug in the treatment of CHD complicated with stable exertional angina pectoris,and can effectively prevent or improve the symptoms of myocardial ischemia in patients.

Key words： Trimetazidine Stable exertional angina pectoris Myocardial ischemia

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Lian-di

Cite this article:

CHEN Lian-di. Effect of Trimetazidine on myocardial ischemia in patients with coronary heart disease complicated with stable exertional angina pectoris[J]. 中国当代医药, 2017, 24(1): 62-64.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I1/62

[15]	曹东华，刘溯，杨宇红.曲美他嗪对老年慢性心力衰竭患者心率变异性影响的研究[J].临床和实验医学杂志，2015，14（17）：1451-1453.
[16]	刘善宽[1].参麦注射液联合曲美他嗪治疗冠心病心绞痛的临床疗效评价[J].中国现代医生，2016，54（6）：111-114.
[1]	范佛远.阿托伐他汀联合曲美他嗪治疗冠心病稳定性心绞痛临床效果观察[J].中国临床新医学，2016，9（7）：621-623.
[2]	Lv J，Zhao X，Ye J，et al.Hollow fiber-based liquid membrane microextraction combined with high-performance liquid chromatography for extraction and determination of trimetazidine in human plasma[J].Biomed Chromatogr，2013，27（3）：292-298.
[3]	来路生.盐酸曲美他嗪对社区冠心病稳定劳力型心绞痛的疗效分析[J].临床医学研究与实践，2016，1（10）：56.
[4]	徐庚许，邹红，黄江，等.速效救心丸与复方丹参滴丸治疗冠心病心绞痛的临床效果与经济性比较[J].中国当代医药，2015，22（33）：106-108.
[5]	王莉.曲美他嗪治疗冠心病心肌缺血35例的临床效果观察[J].转化医学电子杂志，2014，1（3）：62.
[6]	李贵麟.曲美他嗪治疗无症状性心肌缺血疗效观察[J].中西医结合心血管病杂志（电子版），2015，3（28）：105-106.
[7]	龚世峰.曲美他嗪在慢性心肌缺血患者中的临床应用[J].现代实用医学，2014，26（12）：1493-1494.
[8]	鲍菊敏.曲美他嗪治疗66例老年冠心病无症状心肌缺血的临床观察[J].内蒙古中医药，2014，33（12）：28.
[9]	黄贵祥.曲美他嗪治疗稳定型心绞痛40例临床观察[J].中国民族民间医药，2015，24（8）：61.
[10]	何花女.曲美他嗪辅助治疗缺血性心脏病30例临床观察[J].中国民族民间医药，2015，24（15）：90-91.
[11]	张云端，于兆海，邱中敏.参芪合剂治疗冠心病心绞痛气虚血瘀证的临床研究[J].中国当代医药，2015，22（9）：97-100，103.
[12]	刘肖林.心通口服液治疗冠心病心绞痛患者的临床疗效观察[J].中国医学创新，2014，11（14）：109-110.
[13]	吴松华，吴节荣，黄太峰，等.冠心宁注射液治疗心绞痛临床观察[J].中国医学创新，2014，11（4）：41-43.
[14]	钟雨霞.阿托伐他汀钙联合曲美他嗪治疗冠心病的有效性及安全性观察[J].医学理论与实践，2016，29（13）：1719-1720.